|
1 Sancho, E., Batlle, E. &; Clevers, H. Live and let die in the intestinal epithelium. Curr. Opin. Cell Biol. 15, 763-770, (2003). 2 Almeida, M., Han, L., Bellido, T., Manolagas, S. C. &; Kousteni, S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 280, 41342-41351, (2005). 3 Thomas, S. M. et al. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Research 66, 11831-11839, (2006). 4 Kolch, W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature Reviews Molecular Cell Biology 6, 827-837, (2005). 5 Fang, J. Y. &; Richardson, B. C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6, 322-327, (2005). 6 Downward, J. Targeting ras signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22, (2003). 7 Jho, E. H. et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22, 1172-1183, (2002). 8 Leung, J. Y. et al. Activation of AXIN2 expression by beta-catenin-T cell factor - A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277, 21657-21665, (2002). 9 Katanaev, V. L., Ponzielli, R., Semeriva, M. &; Tomlinson, A. Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120, 111-122, (2005). 10 Nusse, R. Cell biology - Relays at the membrane. Nature 438, 747-749, (2005). 11 Paez, J. G. et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304, 1497-1500, (2004). 12 Ung, C. Y. et al. Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk. FEBS Lett. 582, 2283-2290, (2008). 13 Orton, R. J. et al. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem. J. 392, 249-261, (2005). 14 De Falco, V. et al. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Research 67, 381-390, (2007). 15 Fu, Z. et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66, 248-256, (2006). 16 Li, H. Z. et al. Effects of Raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol. Cancer Res. 6, 917-928, (2008). 17 Shin, S.-Y. et al. Functional Roles of Multiple Feedback Loops in Extracellular Signal-Regulated Kinase and Wnt Signaling Pathways That Regulate Epithelial-Mesenchymal Transition. Cancer Research 70, 6715-6724, 2010). 18 Shin, S.-Y. et al. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway. Journal of Cell Science 122, 425-435, (2009). 19 Garofalo, R. S. et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112, 197-208, (2003). 20 Yang, Z. Z. et al. Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 32, 350-354, (2004). 21 Faratian, D. et al. Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab. Cancer Research 69, 6713-6720, (2009). 22 Kumar, N., Afeyan, R., Kim, H. D. &; Lauffenburger, D. A. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Molecular Pharmacology 73, 1668-1678, (2008). 23 Orton, R. et al. Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway. BMC Systems Biology 3, 100 (2009). 24 Kim, D., Rath, O., Kolch, W. &; Cho, K. H. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways. Oncogene 26, 4571-4579, (2007). 25 Sturm, O. E. et al. The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier. Science Signaling 3, (2010). 26 Vera, J. et al. Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models. Molecular BioSystems 6 (2010). 27 Avraham, R. &; Yarden, Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nature Reviews Molecular Cell Biology 12, 104-117, (2011). 28 Naruo, Y. et al. Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity. BMC Systems Biology 5,(2011). 29 Back, T. &; Schwefel, H. P. An Overview of Evolutionary Algorithms for Parameter Optimization. Evol. Comput. 1, 1-23, (1993). 30 Zobeley, J., Lebiedz, D., Kammerer, J., Ishmurzin, A. &; Kummer, U. A new time-dependent complexity reduction method for biochemical systems. Transactions on Computational Systems Biology I, 90-110 (2005). 31 Hoops, S. et al. COPASI- A COmplex PAthway SImulator. Bioinformatics 22, 3067-3074, (2006). 32 Lion, S. et al. An extension to the metabolic control theory taking into account correlations between enzyme concentrations. Eur. J. Biochem. 271, 4375-4391, (2004). 33 Gibson, M. A. &; Bruck, J. Efficient exact stochastic simulation of chemical systems with many species and many channels. J. Phys. Chem. A 104, 1876-1889, (2000). 34 Tyson, J. J., Chen, K. C. &; Novak, B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr. Opin. Cell Biol. 15, 221-231, (2003). 35 Brown, K. S. et al. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys. Biol. 1, 184-195, (2004). 36 Park, S., Yeung, M. L., Beach, S., Shields, J. M. &; Yeung, K. C. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 24, 3535-3540, (2005). 37 Zaravinos, A., Bizakis, J. &; Spandidos, D. A. RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae. Cancer Letters 264, 288-298, (2008). 38 Burack, W. R. &; Sturgill, T. W. The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36, 5929-5933, (1997). 39 Davies, S. P., Reddy, H., Caivano, M. &; Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105, (2000). 40 Schoeberl, B. et al. Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis. Science Signaling 2, (2009). 41 Gould, A. E. et al. Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors. J. Med. Chem. 54, 1836-1846, (2011).
|